Januvia vs. Actos

See how Januvia and Actos compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Januvia and Actos both lower blood sugar in type 2 diabetes but work differently: Januvia boosts the body's own insulin release, while Actos improves how cells respond to insulin.

  • Actos carries a boxed warning for heart failure risk, while Januvia has no boxed warning but has been linked to severe joint pain and a possible heart failure signal in its drug class.

  • Januvia is taken at one fixed daily dose chosen by kidney function, while Actos often starts lower and is increased over time to a higher maintenance dose.

Januvia vs. Actos Drug Summary

Januvia

Januvia (sitagliptin) is a DPP-4 inhibitor used to control blood sugar in adults with type 2 diabetes. It's taken as one tablet a day with no titration needed. The dose is set based on kidney function rather than increased over time.

Actos

Actos (pioglitazone) is a thiazolidinedione that lowers blood sugar in adults with type 2 diabetes, used alone or with other diabetes medications. It's taken once daily and may start lower before increasing to a higher maintenance dose. It carries a boxed warning for heart failure risk.

Januvia vs. Actos Side Effects

Januvia

Most common
upper respiratory tract infection (up to 15.5%)
headache (up to 5.5%)
nasopharyngitis (up to 11.0%)
peripheral edema (up to 8.3%)

Actos

Most common
upper respiratory tract infection (up to 13.2%)
headache (up to 9.1%)
sinusitis (up to 6.3%)
myalgia (up to 5.4%)

Januvia vs. Actos Dosage

Januvia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg once daily At the start
Maximum dose 25 mg once daily If needed
Dose changes 2 increases As tolerated

Actos

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 15 mg once daily At the start
Maximum dose 45 mg once daily If needed
Dose changes 2 increases As tolerated

Januvia vs. Actos Indications

Januvia

Januvia is approved to improve blood sugar control in adults with type 2 diabetes, used alongside diet and exercise. It's often added when other oral medications aren't enough on their own. It is not approved for type 1 diabetes or diabetic ketoacidosis.

  • Blood sugar control in type 2 diabetes

  • Used together with diet and exercise

  • Often combined with metformin or other oral drugs

  • Not approved for type 1 diabetes or DKA

Actos

Actos treats type 2 diabetes as monotherapy or combined with other diabetes medications. It's also used off-label for nonalcoholic fatty liver disease, or NASH. It is not approved for type 1 diabetes or diabetic ketoacidosis.

  • Blood sugar control in type 2 diabetes

  • Can be used alone or with other diabetes drugs

  • Off-label use for fatty liver disease (NASH)

  • Not approved for type 1 diabetes or DKA

Januvia vs. Actos Pros and Cons

Januvia

Januvia helps the body release more insulin after meals and is generally well tolerated, without the heart failure warning seen on older diabetes drugs. It doesn't typically cause weight gain or hypoglycemia when used alone, though the dose needs adjusting for reduced kidney function.

Pros

  • No boxed warning, unlike Actos's heart failure warning

  • Weight-neutral profile, doesn't typically cause weight gain

  • No added risk of bladder cancer or bone fractures

  • Simple once-daily dosing with no titration schedule

Cons

  • Rare reports of severe, disabling joint pain

  • Possible increased heart failure risk seen with this drug class

  • Postmarketing reports of pancreatitis, including fatal cases

  • Dose must be lowered based on kidney function

Actos

Actos improves how the body's cells respond to its own insulin and has decades of clinical use behind it, with an inexpensive generic version widely available. Its boxed warning for heart failure, along with links to bladder cancer and bone fractures, means it isn't right for everyone.

Pros

  • Does not cause hypoglycemia when used alone

  • Inexpensive generic version widely available

  • Also used off-label for fatty liver disease (NASH)

  • Long track record of use since 1999

Cons

  • Boxed warning for heart failure, contraindicated in advanced cases

  • Increased risk of bladder cancer with long-term use

  • Increased fracture risk in women

  • Requires monitoring for fluid retention and heart symptoms

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.